Company: INMB
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001213900-25-021719
Chunk: 1

Company: Inmune Bio, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 1
---

up to 986,000 shares of common stock (the “Second April 2024 Warrants”) and (iii) warrants issued in the September 2024 Offering
that are exercisable starting March 16, 2025 until March 16, 2030, subject to certain exceptions, at an exercise price of $6.40 per share
for up to 2,341,260 shares of common stock (the “September 2024 Warrants” and together with the April 2024 Warrants and the
Second April 2024 Warrants, the “Warrants”). If the Warrants are all exercised for cash, we would receive approximately $29.9
million. To the extent any of the warrants are exercised on a “cashless” basis, we will not receive any cash proceeds from
the exercise.

Our common stock is listed
on the Nasdaq Capital Market under the symbol “INMB.” On March 6, 2025, the last reported sale price of our common stock on
the Nasdaq Capital Market was $8.02 per share.

Investing in our securities involves significant risks. See “Risk Factors” beginning on page S-7 of this prospectus supplement and in the documents incorporated by reference into this prospectus supplement.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement. Any representation to the contrary is a criminal offense.

|                                                       |     | Per   
 Share |       |     | Total |            |
|:------------------------------------------------------|:----|:------|------:|:----|:------|-----------:|
| Offering price(1) and proceeds to us, before expenses |     | $     | 9.152 |     | $     |  5,231,210 |
| Offering price(2) and proceeds to us, before expenses |     | $     |  9.84 |     | $     |  9,702,240 |
| Offering price(3) and proceeds to us, before expenses |     | $     |  6.40 |     | $     | 14,984,064 |

| (1) | Represents the exercise price of the April 2024 Warrants. |

| (2) | Represents the exercise price of the Second April 2024 Warrants. |

| (3) | Represents the exercise price of the September 2024